HOME >> BIOLOGY >> NEWS
Phage therapy could remove foodborne disease from livestock

WASHINGTON, DC May 19, 2003 -- A bacteria-killing virus found in the feces of some sheep could help remove the dangerous foodborne bacteria Escherichia coli O157:H7 from livestock. Researchers from Evergreen State College in Olympia, Washington present their research today at the 103rd General Meeting of the American Society for Microbiology.

"Here we report a promising new natural way of reducing pathogen concentrations in livestock. This takes advantage of bacteriophages bacteria-killing viruses, harmless to humans and other animals, which have been used extensively as antibiotics in Eastern Europe and the former Soviet Union for over 50 years," says Michael Dyen, one of the study researchers.

Dyen and his colleagues report on a new bacteriophage (CEV1) that they isolated from the feces of sheep naturally resistant to gut colonization by E. coli O157:H7. Preliminary trials of CEV1 in the lab have shown that it can be produced easily and can efficiently infect and kill the bacteria under proper conditions. In model systems reflecting the cow/sheep gut, CEV1 completely eliminated the bacteria in 11 days.

"CEV1 and other carefully-selected phages against E. coli O157:H7 could be used to develop an effective management strategy to eradicate this pathogen from livestock," says Dyen.

Outbreaks of Escherichia coli O157:H7 have been linked to the consumption of hamburger meat, alfalfa sprouts, unpasteurized fruit juice, and even drinking water; more than 75% of the cases can be directly traced to contamination from carrier ruminants. The most recent data suggest that about 28% of the cattle presented for slaughter in the US harbour O157:H7, and similar numbers have been reported in Canada and Europe. The livestock show no signs of illness and the levels are generally low, making contaminated animals hard to identify. Current prevention methodologies have centered on reducing meat contamination in the slaughterhouse and testi
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
19-May-2003


Page: 1 2

Related biology news :

1. Phages point the way to novel targets for antimicrobial drug discovery
2. Targeted therapy knocks out pediatric brain cancer in mice
3. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
4. Columbia research to examine gene influence on severity of peridontal disease, therapy response
5. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
6. The search for a kinder, gentler chemotherapy
7. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
8. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
9. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
10. Jefferson Lab detector technology aids development of cystic fibrosis therapy
11. Stroking up cellular therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... ... March 04, 2020 , ... The Massachusetts ... to the MedTech IGNITE program’s 2020 IGNITE Cohort. The MedTech IGNITE Program is ... and nurture the next generation of medtech founders and entrepreneurs. IGNITE Cohort members ...
(Date:3/2/2020)... ... ... Toronto-based clinical research organization (CRO) and regulatory consulting firm, dicentra , has announced ... Clarksburg on a farm on Beaver Valley Road. , The owners currently operate an ... it would be a great new option for employees to relocate to. , “Part ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... its patent-pending Rebound PRP™ and Rebound PRF® devices are now available to ... generation of regenerative medical devices, that will provide the most affordable, easiest ...
Breaking Biology News(10 mins):
(Date:3/13/2020)... (PRWEB) , ... March 12, 2020 , ... ... with the APC Microbiome Ireland SFI Research Center (APC), a pioneer in the ... the body and play a significant role in human health, based at University ...
(Date:3/10/2020)... ... 10, 2020 , ... Lifecycle Biotechnologies announced today that is has ... be used as a biopharmaceutical and biotechnology production and development campus. Lifecycle is currently ... as its production and development hub. The company expects to relocate from Fort Worth, ...
(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... ... was invited to present the latest breast implant technology at the IMCAS Innovation ... and new innovations in the dermatology, plastic surgery, and aesthetic science industries that ...
(Date:2/21/2020)... ... 2020 , ... In a free session on Tuesday, March 10, ... Lisa Dilworth, BS, MS, Vice President Rare, Orphan and Pediatric Diseases, and Rachael Young, ... to support patients, sites and sponsors. , When planning a rare disease clinical trial, ...
Breaking Biology Technology:
Cached News: